Research
Mixed
High-calorie, high-protein nutritional supplementation and specific supplements (L-alanyl-L-glutamine + PUFAs) can counteract lean mass loss and improve quality of life in heart failure patients, potentially mitigating GLP-1RA-induced sarcopenia.
If you are losing muscle on heart failure medication, ask your doctor about high-protein nutritional supplements. Specific combinations like glutamine and fish oil (PUFAs) have been shown to help increase lean body mass and improve how you feel.
ModerateSupportsMEDIUM confidence
One randomized, double-blind, placebo-controlled trial evaluated the effects of daily supplementation with a combination of L-alanyl-L-glutamine (8 g/day) and PUFAs (6.5 g/day) over three months... the treatment group showed increases in lean body mass and improvements in quality of life.
Why this rating
Based on small clinical trials (n=31, n=38) cited in the review; not large-scale RCTs specifically for GLP-1RA users.
Source
Navigating Sarcopenia Risks in GLP-1RA Therapy for Advanced Heart Failure
Winston Wang et al. · Biomedicines · 2025
DOI 10.3390/biomedicines13051108
narrative_reviewCited 4×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- GLP-1 receptor agonists (GLP-1RAs) such as semaglutide and tirzepatide induce significant lean mass loss (muscle wasting) alongside fat mass loss, which exacerbates sarcopenia and frailty in patients with advanced heart failure.Good
- Exercise training, particularly aerobic interval training and cardiac rehabilitation, is a Class I recommendation that counteracts skeletal muscle wasting and improves functional capacity in heart failure patients.Good
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →